Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatch study aims to predict COPD attacks before they land you in hospital

NCT ID NCT06890767

Recruiting now Knowledge-focused Sponsor: David Ruttens Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will give 50 COPD patients a wearable device to track their heart rate, breathing, oxygen levels, and activity for three months after a severe flare-up. The goal is to understand how symptoms change at home and build a computer model that could one day warn patients and doctors early, potentially preventing future hospital stays.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
wearable mobile device
What this could lead to
If successful, this could lead to a system that predicts COPD flare-ups early, allowing timely treatment and fewer hospital visits.
What could go wrong
This is a small, early-stage study with only 50 participants. It is designed to collect data and build a model, not to test a treatment, so direct patient benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION OF COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE EXACERBATION OF COPD CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ziekenhuis Oost-Limburg

    RECRUITING

    Genk, Limburg, 3600, Belgium

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.